Literature DB >> 7387959

Timolol in operated closed-angle glaucoma.

C I Phillips.   

Abstract

Tonometry in 9 eyes (7 patients) provides some evidence that timolol eye drops are useful in improving control of pressure in eyes operated for closed-angle glaucoma. In cases 1 and 2 (Figs, 1 and 2) this beta 1 and 2 blocker reduced pressure consistently. Case 3 (Fig. 3) showed that timolol 0.5% twice daily was as effective as pilocarpine 2% or 4% with adrenaline 1%. The effect of timolol 0.5% in case 4 (Fig. 4) and case 6 (Fig. 6) was additive to pilocarpine and adrenaline; in case 5 (Fig. 5) it probably improved the effect of adrenaline, but in cases 4 and 5 there may have been some loss of effect with time. Case 7 (Fig. 7) showed a good effect of timolol, reversed on withdrawal, but pressure fell again in spite of continued withholding of timolol. Timolol will be especially valuable in the control of pressure if an operation involving iridectomy has not been completely successful in open-angle glaucoma or more especially in closed-angle glaucoma because it has no effect on the pupil. Miotics will tend to produce posterior pupillary synechiae because aqueous humour will go through the iridectomy, not under the edge of the pupil. The danger will be greater in eyes with closed-angle glaucoma because the pupil is closely applied to the anterior lens surface, which will also tend to produce irritative iridocyclitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387959      PMCID: PMC1043664          DOI: 10.1136/bjo.64.4.240

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.

Authors:  I M Katz; W A Hubbard; A J Getson; A L Gould
Journal:  Invest Ophthalmol       Date:  1976-06

2.  Letter: Practolol in the control of intraocular tension.

Authors:  A Hagedoorn; S T Tjoa
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

3.  Treatment of ocular hypertension with oral beta-adrenergic blocking agents.

Authors:  M Pandolfi; A Ohrström
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

4.  The effect of propranolol on human intraocular pressure.

Authors:  G Coté; S M Drance
Journal:  Can J Ophthalmol       Date:  1968-07       Impact factor: 1.882

5.  The effect of some beta-adrenergic blockers on human intraocular pressure.

Authors:  E D el-Sharaf; E A Haroun; Z Ishaac; T M el-Shewy; A H el-Nassef
Journal:  Exp Eye Res       Date:  1974-09       Impact factor: 3.467

6.  Propranolol as ocular hypotensive agent.

Authors:  C I Phillips; G Howitt; D J Rowlands
Journal:  Br J Ophthalmol       Date:  1967-04       Impact factor: 4.638

7.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

8.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

9.  Atenolol eye drops in glaucoma: a double-masked, controlled study.

Authors:  C I Phillips; S M Gore; M J Macdonald; P M Cullen
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

10.  Practolol (Eraldin) eye drops as an ocular hypotensive agent.

Authors:  J Vale; C I Phillips
Journal:  Br J Ophthalmol       Date:  1973-03       Impact factor: 4.638

View more
  1 in total

Review 1.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.